Home/Filings/4/0001209191-22-058875
4//SEC Filing

Tokman Alexander Y 4

Accession 0001209191-22-058875

CIK 0001681682other

Filed

Nov 27, 7:00 PM ET

Accepted

Nov 28, 5:00 PM ET

Size

4.6 KB

Accession

0001209191-22-058875

Insider Transaction Report

Form 4
Period: 2022-11-23
Tokman Alexander Y
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2022-11-23$0.17/sh+10,000$1,700162,857 total

Issuer

ENDRA Life Sciences Inc.

CIK 0001681682

Entity typeother

Related Parties

1
  • filerCIK 0001334483

Filing Metadata

Form type
4
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 5:00 PM ET
Size
4.6 KB